NBPF10 and neoplasm: The resulting anti-MSLN PET-tracers ([89Zr]Zr-2A10 VH-Fc, 3C9 VH-Fc, and m912) easily distinguished the MSLN-expressingHCT116 tumors as compared to the nontargeted control, [89Zr]-Ab6-VH-Fc, which was not able to distinguish the tumor from background(Figure 3 and SI Figure 6).